These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11812901)

  • 21. Vascular calcification in end-stage renal disease patients.
    Nitta K; Ogawa T
    Contrib Nephrol; 2015; 185():156-67. PubMed ID: 26023025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium loading, calcium accumulation, and associated cardiovascular risks in dialysis patients.
    Klemmer PJ
    Blood Purif; 2005; 23 Suppl 1():12-9. PubMed ID: 15832018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early coronary calcification in children and young adults with end-stage renal disease.
    Lumpaopong A; Mathew AV; John E; Jelnin V; Benedetti E; Testa G; Oberholzer J; Sankary H; Ruiz C
    Transplant Proc; 2007; 39(1):37-9. PubMed ID: 17275470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management of secondary hyperparathyroidism in chronic renal failure.
    Goodman WG
    Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii2-8. PubMed ID: 12771290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review.
    McCullough PA; Sandberg KR; Dumler F; Yanez JE
    J Nephrol; 2004; 17(2):205-15. PubMed ID: 15293519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular calcification in dialysis patients: pathogenesis and consequences.
    Reslerova M; Moe SM
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S96-9. PubMed ID: 12612962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular calcification in end stage renal disease.
    Raggi P
    Contrib Nephrol; 2005; 149():272-278. PubMed ID: 15876850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperphosphataemia as a cardiovascular risk factor -- how to manage the problem.
    Cannata-Andía JB; Rodríguez-García M
    Nephrol Dial Transplant; 2002; 17 Suppl 11():16-9. PubMed ID: 12386251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Can cardiovascular calcifications be prevented in chronic kidney disease?].
    Coen G; Manni M; Mantella D; Splendiani G
    G Ital Nefrol; 2006; 23 Suppl 34():S21-5. PubMed ID: 16633990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
    Mason MA; Shepler BM
    Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins.
    Moe SM; O'Neill KD; Duan D; Ahmed S; Chen NX; Leapman SB; Fineberg N; Kopecky K
    Kidney Int; 2002 Feb; 61(2):638-47. PubMed ID: 11849407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor correlation between coronary artery calcification and obstructive coronary artery disease in an end-stage renal disease patient.
    Tong LL; Mehrotra R; Shavelle DM; Budoff M; Adler S
    Hemodial Int; 2008 Jan; 12(1):16-22. PubMed ID: 18271835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial calcification in dialysis patients and transplant recipients.
    Caplin B; Wheeler DC
    Semin Dial; 2007; 20(2):144-9. PubMed ID: 17374089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphate binders, cardiovascular calcifications and mortality: do we need another survival study with sevelamer?
    Negri AL
    J Nephrol; 2010; 23(6):653-7. PubMed ID: 20349415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular calcification burden of Chinese patients with chronic kidney disease: methodology of a cohort study.
    Liu ZH;
    BMC Nephrol; 2015 Aug; 16():129. PubMed ID: 26238717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electron beam tomography as a non invasive method to monitor effectiveness of antiatherosclerotic therapy.
    James G; Raggi P
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Jun; 4(2):177-81. PubMed ID: 15180489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL; Swan VJ; Jamal SA
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis].
    Nitta K
    Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular care in end-stage renal disease.
    McCullough PA
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):245. PubMed ID: 15241738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.